Stimulants—Including Cocaine

  • Marc A. Schuckit
Chapter
Part of the Critical Issues in Psychiatry book series (CIPS)

Abstract

Stimulants are widely and greatly misused medications that have very limited bona fide medical users. It is imprtant that the clinician know these drugs well, as their misuse can mimic a variety of medical and psychiatric syndromes.

Keywords

England Journal Neuroleptic Malignant Syndrome Truck Driver Cocaine Abuse Biological Psychiatry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gawin, F., and Ellinwood, E. Cocaine and other stimulants. New England Journal of Medicine 318: 1173–1182, 1988.PubMedCrossRefGoogle Scholar
  2. 2.
    Kleber, H. Cocaine abuse and its treatment. Journal of Clinical Psychiatry 49(Supplement):1–38, 1988.Google Scholar
  3. 3.
    Schuckit, M. Cocaine: An update. Drug Abuse and Alcoholism Newsletter 17 (15): 1–4, 1988.Google Scholar
  4. 4.
    Jaffe, J. H. Drug addiction and drug abuse. In A. G. Gilman, L. S. Goodman, T. W. Rall, and F. Murad (Eds.), The Pharmacological Basis of Therapeutics ( 7th ed. ). New York: Macmillan, 1985, pp. 532–581.Google Scholar
  5. 5.
    Spitz, H. I., and Rosecan, J. S. (Eds.). Cocaine Abuse: New Directions in Treatment and Research. New York, Brunner/Mazel, 1987.Google Scholar
  6. 6.
    Ellinwood, E. H., Jr. Amphetamine psychosis: Individuals, settings, and sequences. In E. H. Ellinwood and S. Cohen (Eds.), Current Concepts on Amphetamine Abuse. Rockville, Maryland: National Institute of Mental Health, 1970, pp. 143–157.Google Scholar
  7. 7.
    Sato, M. Acute exacerbation of methamphetamine psychosis and lasting doparninergic supersensitivity-A clinical survey. Paper presented at the American College of Neuropsychopharmacology Annual Meeting, Maui, Hawaii, December 10, 1985.Google Scholar
  8. 8.
    Sato, M., Chen, C. C., Akiyama, S., and Otsuki, S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biological Psychiatry 18: 429–440, 1983.PubMedGoogle Scholar
  9. 9.
    Crichlow, S. Khat-induced paranoid psychosis. British Journal of Psychiatry 150: 247–249, 1987.CrossRefGoogle Scholar
  10. 10.
    Mayberry, J., Morgan, G., and Perkin, E. Khat-induced schizophreniform psychosis in the United Kingdom. Lancet 1: 455, 1984.Google Scholar
  11. 11.
    Kozel, N. II., and Adams, E. H. Cocaine Use in America: Epidemiologic and Clinical Perspectives. Rockville, Maryland: Department of Health and Human Services, NIDA Research Monograph 61, 1985, pp. 130–150.Google Scholar
  12. 12.
    Franz, D. N. Central nervous system stimulants. In A. G. Gilman, L. S. Goodman, T. W. Rail, and F. Murad (Eds.), The Pharmacological Basis of Therapeutics ( 7th ed. ). New York: Macmillan, 1985, pp. 582–588.Google Scholar
  13. 13.
    Ritz, M. C., Lamb, R. J., Goldberg, S. R., and Kuhar, M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219–1223, 1987.Google Scholar
  14. 14.
    Angrist, B., Corwin, J., Bartlik, B., and Cooper, T. Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects. Biological Psychiatry 22: 1357–1368, 1987.PubMedCrossRefGoogle Scholar
  15. 15.
    Brower, K. J., Blow, F. C., and Beresford, T. P. Forms of cocaine and psychiatric symptoms. Lancet 1: 50, 1988.PubMedCrossRefGoogle Scholar
  16. 16.
    Wesson, D. R., and Smith, D. E. Low dose benzodiazepine withdrawal syndrome: Receptor site mediated. Newsletter: California Society for the Treatment of Alcoholism and Other Drug Dependencies 9:1–4, Jan./Feb. 1982.Google Scholar
  17. 17.
    Editorial: Crack. Lancet 2: 1061, 1987.Google Scholar
  18. 18.
    Honer, W. G., Gewirtz, G., and Turey, M. Psychosis and violence in cocaine smokers. Lancet 2: 451–452, 1987.PubMedCrossRefGoogle Scholar
  19. 19.
    VanDyke, C., Jatlow, P., Ungerer, J., et al. Oral cocaine: Plasma concentrations and central effects. Science 200: 211–213, 1978.CrossRefGoogle Scholar
  20. 20.
    Javaid, J. I. Cocaine plasma concentration: Relation to physiological and subjective effects in humans. Science 202: 227–228, 1978.PubMedCrossRefGoogle Scholar
  21. 21.
    VanDyke, C., Barash, P. G., Jatlow, P., et al. Cocaine: Plasma concentrations after intranasal application in man. Science 191: 859–861, 1976.CrossRefGoogle Scholar
  22. 22.
    Siegel, R. K. Cocaine smoking. New England Journal of Medicine 300: 373, 1979.PubMedGoogle Scholar
  23. 23.
    Grabowski, J., and Dworkin, S. I. Cocaine: An overview of current issues. International Journal of the Addictions 20: 1065–1088, 1985.PubMedGoogle Scholar
  24. 24.
    Siegel, R. K. Cocaine substitutes. New England Journal of Medicine 302: 817, 1980.PubMedGoogle Scholar
  25. 25.
    Wesson, D. R., and Morgan, J. P. Stimulant look-alikes. Newsletter: California Society for the Treatment of Alcoholism and Other Drug Dependencies 9: 1–4, Oct. 1982.Google Scholar
  26. 26.
    Hurst, P. M. Amphetamines and driving. Alcohol, Drugs, and Driving 3: 13–17, 1987.Google Scholar
  27. 27.
    Byck, R. The effects of cocaine on complex performance in humans. Alcohol, Drugs, and Driving3:9–11, 1987Google Scholar
  28. 28.
    Paul, S. M., Hulihan-Giblin, B., Skolnick, P., et al. Amphetamine binding to rat hypothalamus: Relation to anorexic potency of phenylethylamines. Science 218: 487–489, 1982.PubMedCrossRefGoogle Scholar
  29. 29.
    Sherer, M., Kumor, K., DeBorja, J., et al Psychiatric effects of four-hour infusions of cocaine. Paper presented at the American Psychiatric Association Annual Meeting, Washington, D.C., May 13, 1986.Google Scholar
  30. 30.
    Woolverton, W. L., Kandel, D., and Schuster, C. R. Tolerance and cross-tolerance to cocaine and 6- amphetamine. Journal of Pharmacological Therapy 205: 525–535, 1979.Google Scholar
  31. 31.
    Matsuzaki, M., Spingler, P. J., Misra, A. L., et al Cocaine: Tolerance to its convulsant and cardiorespiratory stimulating effects in the monkey. Life Sciences 19: 193–204, 1976.PubMedCrossRefGoogle Scholar
  32. 32.
    Post, R. M., and Kopanda, R. T. Cocaine, kindling and psychosis. American Journal of Psychiatry 133: 627–634, 1976.PubMedGoogle Scholar
  33. 33.
    American Psychiatric Association. Diagnostic Criteria from the DSM III-R. Washington, D.C., American Psychiatric Press, 1987.Google Scholar
  34. 34.
    Wender, P. H. Minimal brain dysfunction: An overview. In M. A. Lipton, A. DiMascio, and K. F. Killam (Eds.), Psychopharmacology: A Generation of Progress. New York: Raven Press, 1978, pp. 312–321.Google Scholar
  35. 35.
    Schuckit, M., Petrich, J., and Chiles, J. Hyperactivity: Diagnostic confusion. Journal of Nervous and Mental Disease166:79–87, 1978 Google Scholar
  36. 36.
    Gomez, R. L., Janowsky, D., Zetin, M., et al Adult psychiatric diagnosis and symptoms compatible with the hyperactive child syndrome: A retrospective study. Journal of Clinical Psychiatry 42: 389–394, 1981.PubMedGoogle Scholar
  37. 37.
    Douglas, J. G., Preston, P. G., Haslett, C., et al Long-term efficacy of fenfluramine in treatment of obesity. Lancet 1: 384–486, 1983.PubMedCrossRefGoogle Scholar
  38. 38.
    Angrist, B. M., and Gershon, S. Psychiatric sequelae of amphetamine use. In R. I. Shader (Ed.), Psychiatric Complications of Medical Drugs. New York: Raven Press, 1972, pp. 23–35.Google Scholar
  39. 39.
    Smart, R. G., Goodstadt, M. S., Adlaf, E. M., and Sheppard, M. A. Trends in the prevalence of alcohol and other drug use among Ontario students: 1977–1983. Canadian Journal of Public Health 76: 157–161, 1985.Google Scholar
  40. 40.
    Smart, R. G., and Adlaf, E. M. Patterns of drug use among adolescents: The past decade Social Science Medicine 23: 717–719, 1986.PubMedCrossRefGoogle Scholar
  41. 41.
    Nicholi, A. M. The nontherapeutic use of psychoactive drugs. New England Journal of Medicine 308: 925–933, 1983.PubMedCrossRefGoogle Scholar
  42. 42.
    Editorial: National survey finds continuing decline in use of illicit drugs by high school seniors. Hospital and Community Psychiatry 36: 1011, 1985.Google Scholar
  43. 43.
    Smart, R. G., Adlaf, E. M., and Goodstadt, M. S. Alcohol and other drug use among Ontario students: An update. Canadian Journal of Public Health 77: 57–58, 1986.Google Scholar
  44. 44.
    Editorial: Epidemiology of drug usage. Lancet1:147, 1985 Google Scholar
  45. 45.
    Kandel, D. B., and Logan, J. A. Patterns of drug use from adolescent to young adulthood: Periods of risk for initiation, continued use, and discontinuation. American Journal of Public Health 74: 660–666, 1984.PubMedCrossRefGoogle Scholar
  46. 46.
    White, H. R. Longitudinal patterns of cocaine use among adolescents. American Journal of Drug and Alcohol Abuse14:1–15, 1988Google Scholar
  47. 47.
    Siegel, R. K. Cocaine hallucinations. American Journal of Psychiatry 135: 309–314, 1978.PubMedGoogle Scholar
  48. 48.
    Schuckit, M. A. Alcoholism and other psychiatric disorders. Hospital and Community Psychiatry34:1022–1027, 1983PubMedGoogle Scholar
  49. 49.
    Angrist, B. M., and Gershon, S. The phenomenology of experimentally-induced amphetamine psychosis-Preliminary observations. Biological Psychiatry 2: 95–107, 1970.PubMedGoogle Scholar
  50. 50.
    McLellan, A. T., Woody, G. E., and O’Brien, C. P. Development of psychiatric illness in drug abusers. New England Journal of Medicine 301:1310–1314, 1979.Google Scholar
  51. 51.
    Segal, D. S., and Schuckit, M. A. Animal models of stimulant-induced psychosis. In I. Creese (Ed.), Stimulants: Neurochemical, Behavioral, and Clinical Perspectives. New York: Raven Press, 1982, pp. 131–168.Google Scholar
  52. 52.
    Aronson, T. A., and Craig, T. J. Cocaine precipitation of panic disorder. American Journal of Psychiatry 143: 643–645, 1986.PubMedGoogle Scholar
  53. 53.
    Goodwin, D. W., and Guze, S. B. Psychiatric Diagnosis ( 4th ed. ). New York: Oxford University Press, 1988.Google Scholar
  54. 54.
    Kosten, T. R., and Kleber, H. D. Sudden death in cocaine abusers: Relation to neuroleptic malignant syndrome. Lancet 1:1198, 1987.Google Scholar
  55. 55.
    Fischman, M. W. Cocaine and the amphetamines. In H. Y. Meltzer (Ed.), Psychopharmacology: The Third Generation of Progress. New York: Raven Press, 1987, pp. 1543–1554.Google Scholar
  56. 56.
    Gold, M. S. 800-COCAINE: Survey of 500 callers. Paper presented at the Biological Psychiatry Annual Meeting, Chicago, May 5, 1986.Google Scholar
  57. 57.
    Smart, R. G., and Anglin, L. Do we know the lethal dose of cocaine? Journal of Forensic Sciences 32: 303–312, 1987.PubMedGoogle Scholar
  58. 58.
    Wetli, C. V., and Fisbain, D. A. Cocaine-induced psychosis and sudden death in recreational cocaine users. Journal of Forensic Sciences 30: 873–880, 1985.PubMedGoogle Scholar
  59. 59.
    Kosten, T., and Kleber, H. Rapid death during cocaine abuse. American Journal of Drug and Alcohol Abuse 14: 335–346, 1988.PubMedCrossRefGoogle Scholar
  60. 60.
    Catravas, J. D., Waters, I. W., Walz, M. A et al. Antidotes for cocaine poisoning. New England Journal of Medicine 301:12381977 Google Scholar
  61. 61.
    Angrist, M. D., Less, H. K., and Gershon, S. The antagonism of amphetamine-induced symptomatology by a neuroleptic. American Journal of Psychiatry 131:817–821, 1974.Google Scholar
  62. 62.
    Rappolt, R. T. Propranolol in cocaine toxicity. Lancet 2: 640–641, 1976.PubMedCrossRefGoogle Scholar
  63. 63.
    Espelin, D. E., and Done, A. K. Amphetamine poisoning: Effectiveness of chlorpromazine. New England Journal of Medicine278:1361–1365, 1978Google Scholar
  64. 64.
    Sternback, H. Pemoline-induced mania. Biological Psychiatry 16: 987–989, 1981.Google Scholar
  65. 65.
    Ando, K., Hironaka, N., and Yanagita, T. Psychotic manifestations in amphetamine abuse-Experimental study on the mechanisms of psychotic recurrence. Psychopharmacology Bulletin 22: 763768, 1986.Google Scholar
  66. 66.
    Sherer, M., Kumor, K., Golden, R., and Jaffe, J. Continuous infusion of cocaine-A model for cocaine psychosis? Paper presented at the Society of Biological Psychiatry Annual Meeting, Washington, D.C., May 10, 1986.Google Scholar
  67. 67.
    Nielsen, E. B., and Lyon, M. Behavioral alterations during prolonged low level continuous amphetamine administration in a monkey family group (Cercopithecus aethiops). Biological Psychiatry 17: 423–435, 1982.PubMedGoogle Scholar
  68. 68.
    Griffith, J. D., Cavanaugh, J. H., and Oates, J. A. Psychosis induced by the administration of D-amphetamine to human volunteers. In D. H. Efron (Ed.), Psychotomimetic Drugs. New York: Raven Press, 1970.Google Scholar
  69. 69.
    Bell, D. S. The experimental reproduction of amphetamine psychosis. Archives of General Psychiatry 29: 35–40, 1973.PubMedCrossRefGoogle Scholar
  70. 70.
    Ellinwood, E. H., Jr. Assault and homicide associated with amphetamine abuse. American Journal of Psychiatry127:1170–1176, 1971PubMedGoogle Scholar
  71. 71.
    Perkins, K. A., Simpson, J. C., and Tsuang, M. T. Ten-year follow-up of drug abusers with acute or chronic psychosis. Hospital and Community Psychiatry 37: 481–484, 1986.PubMedGoogle Scholar
  72. 72.
    Roberts, D. Self-increased–self-administration of cocaine following haloperidol. Pharmacology, Biochemistry and Behavior 26: 37–43, 1987.CrossRefGoogle Scholar
  73. 73.
    Kumor, K., Sherer, M., and Jaffe, J. Haloperidol-induced dystonia in cocaine addicts. Lancet 2: 1341–1342, 1986.PubMedCrossRefGoogle Scholar
  74. 74.
    Dimijian, G. G. Differential diagnosis of emergency drug reactions. In P. G. Boume (Ed.). A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974, pp. 1–7.Google Scholar
  75. 75.
    Grant, I., Mohns, L., Miller, M., and Reitan, R. M. A neuropsychological study of polydrug users. Archives of General Psychiatry 33: 973–978, 1976.PubMedCrossRefGoogle Scholar
  76. 76.
    Grant, I., Adams, K. M., Carlin, A. S., et al Organic impairment in polydrug users: Risk factors. American Journal of Psychiatry135:178–184, 1978PubMedGoogle Scholar
  77. 77.
    Gawin, F. H., and Kleber, H. D. Neuroendocrine findings in chronic cocaine abusers: A preliminary report. British Journal of Psychiatry 147: 569–573, 1985.PubMedCrossRefGoogle Scholar
  78. 78.
    Weiss, R. D., Mirin, S. M., Michael, J. L., and Sollogub, A. C. Psychopathology in chronic cocaine abusers. American Journal of Drug and Alcohol Abuse 12:17–129, 1986.Google Scholar
  79. 79.
    Gawin, F. H., and Kleber, H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Archives of General Psychiatry43:107–113, 1986PubMedCrossRefGoogle Scholar
  80. 80.
    Roehrich, H., Dackis, C. A., and Gold, M. S. Bromocriptine. Medicinal Research Reviews 7: 243–269, 1987.PubMedCrossRefGoogle Scholar
  81. 81.
    Gutierrez-Esteinou, R. Interactions of bromocriptine with cocaine. American Journal of Psychiatry 145: 1173, 1988.PubMedGoogle Scholar
  82. 82.
    Curran, J. W., Jaffe, H. W., Hardy, A. M., et al. Epidemiology of HIV infection and AIDS in the United States. Science 239:610–616, 1988 PubMedCrossRefGoogle Scholar
  83. 83.
    American Psychiatric Association, Committee on Drug Abuse. Position statement on psychoactive substance use and dependence: Update on marijuana and cocaine. American Journal of Psychiatry 144: 698, 1987.Google Scholar
  84. 84.
    Schachne, J. S., Roberts, B. H., and Thompson, P. D. Coronary-artery spasm with myocardial infarction: Association with cocaine use. New England Journal of Medicine 310:1665–1666, 1984.Google Scholar
  85. 85.
    Isner, J. M., Estes, N. A. M., Thompson, P. D., et al. Acute cardiac events temporally related to cocaine abuse. New England Journal of Medicine315:1438–1443, 1986PubMedCrossRefGoogle Scholar
  86. 86.
    Woods, J. R., Plessinger, M. A., and Clark, K. E. Effect of cocaine on uterine blood flow and fetal oxygenation. Journal of the American Medical Association 257: 957–961, 1987.PubMedCrossRefGoogle Scholar
  87. 87.
    Chasnoff, I. J., Bums, W. J., Schnoll, S. H., and Burns, K. A. Cocaine use in pregnancy. New England Journal of Medicine 313: 666–669, 1985.PubMedCrossRefGoogle Scholar
  88. 88.
    Smith, C. G., and Asch, R. H. Drug abuse and reproduction. Fertility and Sterility 48: 355–373, 1987.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Marc A. Schuckit
    • 1
  1. 1.San Diego School of Medicine, Veterans Administration HospitalUniversity of CaliforniaSan DiegoUSA

Personalised recommendations